<DOC>
	<DOCNO>NCT00734994</DOCNO>
	<brief_summary>Hypothesis : In select patient external hyperthermia use combination intravesical Mitomycin-C ( MMC ) treat recurrent transitional cell carcinoma ( TCC ) bladder local resection standard adjuvant therapy thus prevent delay recurrence need radical cystectomy .</brief_summary>
	<brief_title>Mitomycin C With Hyperthermia Intravesical Mitomycin C Treat Recurrent Bladder Cancer</brief_title>
	<detailed_description>It well establish tumor cell sensitive heat combine chemotherapeutic agent , drug uptake intracellular distribution drug within malignant cell improve due increase cellular permeability . Further , hyperthermia inhibits deoxyribonucleic acid ( DNA ) repair result increase reaction DNA chemotherapy . By heat bladder tissue accelerate necessary series reaction link agent mitomycin C cell DNA , effect may optimize . Depending extent resection ( location , size , depth invasion remain tumor ) transurethral resection bladder tumor ( TURBT ) , recommend adjuvant therapy consist intravesical chemotherapy . MMC study dos high 80 mg without produce significant irreversible side effect . The commonly use dose mitomycin 40 mg.2 This pilot study propose use Mitomycin C dose 40 mg conjunction deep hyperthermia enhance effect intravesical chemotherapy second-line treatment recurrent TCC ( Stage Ta , T1 , Tis ) bladder surgical resection standard adjuvant therapy .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Nonmuscle invasive transitional cell carcinoma ( TCC ) bladder ( Ta , T1 , Tis ) recurrent initial surgery least one round adjuvant treatment ( i.e . 6 week intravesical biological therapy Bacillus Calmette Guerin ( BCG ) solution ) ; An inability tolerate BCG Age &gt; 18 Eastern Cooperative Oncology Group ( ECOG ) Performance Status 02 Laboratory test perform within 14 day study enrollment : Leukocytes ≥ 3,200 , Absolute Neutrophil count ≥ 1,500 , Platelets ≥ 100,000 Hemoglobin ≥ 9.0 gm/dL , Total bilirubin ≤ institution upper limit normal * ( ULN ) , Asparate Aminotransferase ( AST ) Alanine Aminotransferase ( ALT ) ≤ 2.5 time ULN , Alkaline phosphatase ≤ 2.5 time ULN Creatinine ≤ 1.5 time ULN Women child bear potential must negative pregnancy test If postmenopausal Amenorrhea ≥ 12 month Pregnancy breastfeed Muscle invasive disease ( T2T4 ) Prior radiation pelvis Peripheral neuropathy ( grade ) Thrombocytopenia , coagulation disorder increase bleeding tendency due cause Known bladder fistula Hypersensitive idiosyncratic reaction mitomycinC component past</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>